Glucotrack Acquires Lōkahi Therapeutics in Strategic Business Combination

Glucotrack, Inc. completed its strategic business combination with Lōkahi Therapeutics to establish a publicly listed, capital-efficient healthcare assets platform. The structure makes Lōkahi Therapeutics the operating and controlling business of the combined company, with Lōkahi Therapeutics securityholders receiving Glucotrack stock; they are expected to hold about 90% on a fully diluted basis.